Clinical Director of NIHR / CRUK, Christie Research Facility
0161 446 8138
0161 446 8408
MB ChB MRCP MSc MD FRCP
Breast cancer treatment and research
Breast cancer treatment and research; Clinical Director of The Christie/NIHR Clinical Research Facility; Clinical Lead for Systemic Anti-Cancer Therapy; Chair of Systemic Therapies Research theme; member of The Christie Research Strategy Committee.
Member of the Experimental Medicine Strategy Board at Manchester Academic Health Science Centre; member of the strategy group at Manchester Cancer Research Centre; member of NHS England chemotherapy clinical reference group; member of National Cancer Research Institute’s breast cancer clinical studies group, Principal investigator and Lead of Clinical Research Group within Manchester Breast Centre, Speciality lead for Cancer Research in Greater Manchester Clinical Research Network (NIHR Greater Manchester CLRN), NCIN Chemotherapy Clinical Information Group.
Dr Wardley has been Consultant Medical Oncologist for breast cancer at The Christie since 2001. He led the Christie Hospital Breast Cancer Research Team to become the most successful breast cancer research team in the UK. He has an international reputation for breast cancer research. In 2005 he was one of the founding members of Manchester Breast Centre (MBC). Dr Wardley has been Clinical Director of the Early Phase Trials Unit since December 2011 and led the successful bid for £4.5M funding from the National Institute for Health Research for clinical research facilities. He formed and chairs The Christie Early Phase Trials Group, which aims to promote the rapid development of new targeted therapies and innovative treatments in cancer care, and to promote the advancement of personalised medicine. Dr Wardley has been Clinical Lead for Systemic Anti-Cancer Therapy since February 2011 and Chair is of Systemic Therapies Research Theme. He is committed to excellence through personal involvement in direct patient care, training, audit, research and effecting change.
Clinical trials in breast cancer and Early-phase clinical trials